Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
(OP:
NUMIF
)
0.0332
-0.0008 (-2.35%)
Streaming Delayed Price
Updated: 2:51 PM EDT, Jun 25, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about NUMIF
< Previous
1
2
3
4
5
6
7
8
9
Next >
Numinus' Ongoing Collaboration With Health Canada Spurs Mindspace Clinic Approval In Quebec
May 24, 2022
A longstanding commitment of Numinus Wellness Inc. (OTC: NUMIF) to collaborate with Health Canada to help shape protocols for the Special Access Program appears to be paying dividends.
Via
Benzinga
3 of 5 Cannabis Categories Declined During Third Week Of May
May 22, 2022
The cannabis sector consists of 5 distinct categories and they each performed quite differently from each other during the third week of May.
Via
Talk Markets
Psyched: Compass, Atai And MindMed Release Q1 Earnings, Phase 3 MDMA Trial Closer To Completion, Enveric Splits Into Two Companies
May 17, 2022
The psychedelics space got a new glimpse at the financials of some of its heavy hitters with the release of earnings reports for the first quarter of 2022.
Via
Benzinga
Numinus Granted Canada's Special Access Program For Magic Mushrooms To Treat Life-Threatening Conditions
May 16, 2022
Numinus Wellness Inc (OTCQB: NUMIF) has been approved to use psilocybin-assisted therapy through Health Canada’s Special Access Program (SAP), marking the first instance in which Numinus will provide...
Via
Benzinga
Numinus to Acquire Novamind For $20.74M In Stock
April 12, 2022
Via
Benzinga
2 Of The 5 Cannabis Categories Advanced Slightly During Second Week Of May
May 14, 2022
The cannabis sector consists of 5 distinct categories, each performing differently from the other. Here, the stock performances during the second week of May, YTD and from the 2021 peak.
Via
Talk Markets
Novamind And Numinus Prepare For Acquisition, Both Companies Share Info Circulars To Shareholders
May 11, 2022
June 8, 2022 marks a turning point for both Numinus (OTCQX: NUMIF) and Novamind (OTCQB: NVMDF).
Via
Benzinga
Novamind To Offer Virtual Mental Health Therapy Sessions
May 02, 2022
Novamind (OTCQB: NVMDF), which is to be acquired by Numinus Wellness (OTCMKTS: NUMIF), recently announced a collaboration with health coaching platform HealCommunit
Via
Benzinga
Numinus Wellness Strives To Become Psychedelic Research Hub After Acquisition Of Novamind Inc.
April 13, 2022
In a year where M&A activity is expected to ratchet-up in 2022, Numinus Wellness Inc. (OTC: NUMIF) is among the first to take action.
Via
Benzinga
Psyched: Atai, MindMed, Enveric and Mydecine Release 2021 Earnings, Bienstar Expands To Brazil & More!
April 06, 2022
It’s earnings week in the psychedelics space, opening a new window into the financial situations of many companies in the sector.
Via
Benzinga
March Update: Psychedelic Compounds-Based Drug Stocks Index Went Down -19%
April 01, 2022
An update on the revisions that have been made to the Pure-Play Psychedelic Compounds-Based Drug Stocks Index with the increase in the minimum market capitalization required to be included in the...
Via
Talk Markets
Numinus Administers MDMA To First Volunteer In Clinical Trial Sponsored By MAPS
March 30, 2022
Numinus Wellness Inc. (OTCQX: NUMIF), announced that clinical trial MAPPUSX has gotten underwaywith the enrolling and dosing ...
Via
Benzinga
Psychedelic Compounds-Based Drug Stocks Down Slightly This Past Week
March 27, 2022
We're tracking 13 public companies (US and/or Canada) doing clinical-stage research into THC and/or psychedelics for treating mental illnesses. While a few were up this week, the overall trend...
Via
Talk Markets
Cannabis Movers & Shakers: TGOD, Numinus Wellness, GTI, Neptune Wellness
February 18, 2022
The Green Organic Dutchman Names New CFO The Green Organic Dutchman Holdings Ltd. (CSE:
Via
Benzinga
Benzinga's Unprecedented Psychedelics Investing Conference Lands In Miami On April 19th
February 09, 2022
The first Benzinga Psychedelics Capital Conference, the premier gathering of psychedelics industry leaders and forward-thinking investors, is coming to the Fontainebleau Miami Beach on April 19, 2022,...
Via
Benzinga
Psyched: Psychedelics ETF Launches On NYSE, Psilocybin Trial Approved For Depression, DMT Study Begins
February 07, 2022
This week saw new triumphs for public companies in the psychedelics space with the creation of a new ETF tracking the sector, which went public in the NYSE.
Via
Benzinga
Psychedelic Stocks Finally In An Upswing
February 06, 2022
The Marijuana & Psychedelic Compounds-Based Drug Stocks Index went up +5.3% last week.
Via
Talk Markets
Psychedelics Co. Numinus Wellness Appoints New Bioscience Advisors To Bolster IP Development
February 01, 2022
Psychedelics-focused company Numinus Wellness Inc. (TSX:NUMI) (OTCQX: NUMIF) announced the appointment of three key advisors to its new Bioscience Advisory Board.
Via
Benzinga
The Psychedelic & Marijuana Drug Stocks Index Dropped -30% In January
January 30, 2022
This article updates the performances of 16 clinical-stage psychedelic and marijuana drug companies researching the treatment of a wide variety of mental illnesses.
Via
Talk Markets
Psyched: Eleusis To Go Public Via Merger, New Psychedelics Bills In Utah, Virginia, Kansas And Missouri
January 24, 2022
Psychedelics Legalization Gains Momentum Around The Country: Bills Introduced In Utah, Virginia, Kansas And Missouri A wave of psychede...
Via
Benzinga
Weekend Update: Only 2 Psychedelic Drug Stocks Are Up YTD
January 23, 2022
This article updates the performances of the 16 largest capitalized clinical-stage psychedelic and marijuana drug companies researching the treatment of a wide variety of mental illnesses out of a...
Via
Talk Markets
Numinus Wellness Reveals 244.5% YoY Improvement In Q1 Revenue & Wider Loss
January 21, 2022
Numinus Wellness Inc (TSX:NUMI) (OTC:
Via
Benzinga
Marijuana & Psychedelic Drug Stocks Continue To Decline
January 16, 2022
The Marijuana & Psychedelic Compounds-Based Drug Stocks Index consists of 16 of the 100 such companies that trade on North American stock exchanges. 5 of them are marijuana drug stocks and 11 are...
Via
Talk Markets
Pure-Play Marijuana- & Psychedelic Compounds-Based Drug Stocks Index Is Down By 66% From 2021 High
January 09, 2022
There are 16 remaining constituents of our Marijuana & Psychedelic Compounds-Based Drug Stocks Index is now DOWN -65.9% from its highs in 2021. Here are the details for each of its constituents.
Via
Talk Markets
Steep Decline In Cannabis & Psychedelic Compounds-Based Drug Stocks Continues: DOWN -16.6% MTD
December 24, 2021
All 12 constituents in the Marijuana & Psychedelic Compounds-Based Drug Stocks Index continue to decline. How do their performances compare month-to-date and YTD?
Via
Talk Markets
The Year In Review For Psychedelic Drug Stocks: 2021
December 21, 2021
2021 was two different
Via
Talk Markets
Psychedelics Company Numinus Wellness Q4 Revenue Grows 81% YoY Thanks To Mindscape Acquisition
December 10, 2021
Psychedelics-focused mental health care company Numinus Wellness Inc. (TSXV:
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.